From October 2019 to September 2020, 21 percent decrease seen in outpatient department testing, increases observed in other testing strategies
Fourth COVID-19 Vaccine Dose Safe for Immunocompromised
Local and systemic reactions reported less frequently after fourth dose versus dose 3 of primary vaccination series
U.S. Extends COVID-19 Public Health Emergency Another Three Months
Separate emergency declaration allows for the emergency use authorization of testing, treatments, and vaccines